Cellectis S.A.   Report issue

For profit Phase 1 Phase 2
Founded: Paris France (1999)

Organization Overview

First Clinical Trial
2017
NCT03190278
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Cellectis S.A.